well so far all the court cases seem to last years for resolution. Take our Jublia Generic for example.......... ANDA filed 2017(?) orange book...... court case 2018ish, where we in 2022 still don't know the outcome....... even though the US FDA has given us approval for our Jublia Generic ( as well as some 10 others) but ACR cannot launch the product. So if Dapsone follows the same path it'll be 2030 before we are even told how it went.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.339M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $11.58K | 619.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 335415 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 516258 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |